IPO registrations (S-1, F-1) · Registrants

Sana Biotechnology, Inc.

SEC CIK
1770121 · filings on EDGAR ↗
Registration
Form S-1, first filed 2021-01-13, last 2021-02-03; 1 initial registration, 3 amendments
Outcome
Final prospectus filed 2021-02-05; declared effective 2021-02-03
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
DE
Business address
188 EAST BLAINE STREET, SUITE 350, Seattle, WA
EIN
83-1381173
Ticker
SANA (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Sana Biotechnology, Inc. on the corporate pages

Offering terms

Proposed price range
$23.00–$24.00 per share (S-1/A filed 2021-02-03)
Final price
$25.00 per share, above the range (424B4 filed 2021-02-05, an initial public offering)
Shares sold
23,500,000
Gross proceeds
$587,500,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol SANA
Lead underwriters
Morgan Stanley; Goldman Sachs (6,345,000 shares); J.P. Morgan (6,345,000 shares); BofA Securities (4,465,000 shares)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 7

FiledFormWhat it isName as filedEDGAR
2021-01-13S-1S-1 (registration)Sana Biotechnology, Inc.0001193125-21-007483 ↗
2021-01-28S-1/AS-1/A (amendment)Sana Biotechnology, Inc.0001193125-21-019984 ↗
2021-02-02S-1/AS-1/A (amendment)Sana Biotechnology, Inc.0001193125-21-025048 ↗
2021-02-03S-1/AS-1/A (amendment)Sana Biotechnology, Inc.0001193125-21-026330 ↗
2021-02-03S-1MEFS-1MEF (added securities)Sana Biotechnology, Inc.0001193125-21-027709 ↗
2021-02-03EFFECTEFFECT (declared effective)Sana Biotechnology, Inc.9999999995-21-000413 ↗
2021-02-05424B4424B4 (final prospectus)Sana Biotechnology, Inc.0001193125-21-029606 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2021-02-03S-1/Aregistration statement$23.00–$24.0022,000,000-Nasdaq SANA4primary document; range, shares headline, cover names 4document ↗
2021-02-05424B4final prospectus$25.0023,500,000$587,500,000Nasdaq SANA4primary document; price sentence, shares headline, proceeds table, underwriting table 3, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
AFEYAN NOUBARTenPercentOwner62021–2024
AGARWAL SUNILOfficerEVP, Head of Development & CMO; See Remarks52021–2022
ARCH Venture Fund IX, L.P.TenPercentOwner32021–2024
ARCH Venture Fund IX Overage, L.P.TenPercentOwner32021–2024
ARCH Venture Fund X, L.P.TenPercentOwner52021–2024
ARCH Venture Fund X Overage, L.P.TenPercentOwner32021–2024
ARCH Venture Partners IX, LLCTenPercentOwner32021–2024
ARCH Venture Partners IX Overage, L.P.TenPercentOwner32021–2024
ARCH Venture Partners X, LLCTenPercentOwner32021–2024
ARCH Venture Partners X, L.P.TenPercentOwner32021–2024
ARCH Venture Partners X Overage, L.P.TenPercentOwner32021–2024
Bilenker Joshua H.Director102021–2026
Bishop Hans EdgarDirector282021–2026
Burow KristinaTenPercentOwner32021–2024
BYBEE CLINTONTenPercentOwner32021–2024
Cole Douglas G.Director72021–2024
CRANDELL KEITHTenPercentOwner32021–2024
Flagship Pioneering Fund VI General Partner LLCTenPercentOwner32021–2023
Flagship Pioneering Fund VI, L.P.TenPercentOwner32021–2023
Flagship Pioneering Inc.TenPercentOwner42021–2024
Flagship VentureLabs V LLCTenPercentOwner32021–2023
Flagship VentureLabs V Manager LLCTenPercentOwner32021–2023
Flagship Ventures Fund V General Partner LLCTenPercentOwner52021–2023
Flagship Ventures Fund V, L.P.TenPercentOwner52021–2023
Flagship V VentureLabs Rx Fund, L.P.TenPercentOwner52021–2023
GILLIS STEVENTenPercentOwner32021–2024
Hardy NathanOfficerEVP, Chief Financial Officer; SVP, Chief Financial Officer52021–2024
Harr SteveDirector,OfficerPresident & CEO92021–2026
Hordo ChristianOfficerEVP, Chief Business Officer; SVP, Chief Business Officer112021–2024
MacDonald James J.OfficerEVP & General Counsel; See Remarks52021–2022
Mulligan RichardDirector; Director,OfficerHead of SanaX82021–2026
NELSEN ROBERTDirector; Director,TenPercentOwner162021–2026
REICIN ALISEDirector92021–2026
Seitz MichelleDirector92021–2026
von Maltzahn GeoffreyDirector42021
Wilderotter Mary AgnesDirector122021–2025
Yang Patrick YDirector112021–2026
ARCH Venture Partners IX, L.P.TenPercentOwner22021–2024
Cassidy Bernard JOfficerEVP & General Counsel62022–2025
WILLIAMS DOUGLAS EOfficerEVP & President, R&D42023–2024
Flagship Pioneering Fund VII General Partner LLCTenPercentOwner12024
Flagship Pioneering Fund VII, L.P.TenPercentOwner12024
FMR LLCTenPercentOwner,Other32024–2025
Wyrick Susan D.OfficerSee Remarks102024–2026
Rosiello Robert L.Director32025–2026
Piper BrianOfficerEVP, Chief Financial Officer22026
PATEL DHAVALKUMAR DHIRAJLALOfficerEVP, Chief Scientific Officer22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2020-06-26Sana Biotechnology, Inc.Biotechnology$821,097,521$821,097,521401
2020-06-26Sana Biotechnology, Inc.Biotechnology$45,850,000$45,850,00081

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationSana Biotechnology, IncWAState business registriesname and state
Business registrationSana Biotechnology, Inc.WAState business registriesname and state
Business registrationSana Biotechnology, Inc.WAState business registriesname and state
Business registrationSANA BIOTECHNOLOGY, INC.WAState business registriesname and state
Business registrationSANA BIOTECHNOLOGY, INC.WAState business registriesname and state
Business registrationSANA BIOTECHNOLOGY, INC.WAState business registriesname and state
Plan sponsorSANA BIOTECHNOLOGY, INC.WAForm 5500 (employee benefit plans)EIN (EXACT)
Form D issuerSana Biotechnology, Inc.WAForm D private offeringsCIK (EXACT)
Patent assigneeSana Biotechnology, Inc.WAPatents (USPTO)name and state
SEC filerSana Biotechnology, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerSana Biotechnology, Inc.WATrademarks (USPTO)name and state
Form 5500 plan sponsorSANA BIOTECHNOLOGY, INC.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), WA first:

More with this interest.

In other datasets, the same topic (Health) in WA:

Interests: Biological Products, (No Diagnostic Substances) · Health